Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Andreeff M , Drach J, Tafuri A, Estey E, Escudier S, Sanchez-Williams G, Dunne C, Goodacre A, Pereira-Leahy M, Zhao S, Kornblau S, Kantarjian H, Mandelli F, Plunkett W, Deisseroth A
Throughout the 24-month study period, mean systolic BP was lower in the ipragliflozin group than in the placebo group, with the changes in systolic BP correlating significantly with the decrease in body mass index in the ipragliflozin group
41 When continuous variables were missing, we used standard deviations borrowed from other similar randomised controlled trials to calculate the missing standard deviations
Implicit bias in medicine and beyond by Megan A
10.1016/j.jddst.2025.106964 136
US$ 27.91
US$ 27.86
US$ 22.21
